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Abstract
Background: The Wiskott–Aldrich syndrome protein (WASp) family of actin-nucleating factors are present in the
cytoplasm and in the nucleus. The role of nuclear WASp for T cell development remains incompletely defined.
Methods: We performed WASp chromatin immunoprecipitation and deep sequencing (ChIP-seq) in thymocytes
and spleen CD4+ T cells.
Results: WASp was enriched at genic and intergenic regions and associated with the transcription start sites of
protein-coding genes. Thymocytes and spleen CD4+ T cells showed 15 common WASp-interacting genes, including
the gene encoding T cell factor (TCF)12. WASp KO thymocytes had reduced nuclear TCF12 whereas thymocytes
expressing constitutively active WASpL272P and WASpI296T had increased nuclear TCF12, suggesting that regulated
WASp activity controlled nuclear TCF12. We identify a putative DNA element enriched in WASp ChIP-seq samples
identical to a TCF1-binding site and we show that WASp directly interacted with TCF1 in the nucleus.
Conclusions: These data place nuclear WASp in proximity with TCF1 and TCF12, essential factors for T cell
development.
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Background
The actin cytoskeleton is essential for life and regulates
critical cellular functions including morphogenesis, mi-
gration, cytokinesis, membrane transport, and cell-to-
cell communication.
In addition to its fundamental role in the cytoplasm,
actin resides in the nucleus and regulates chromatin re-
modeling, RNA processing, and nucleoskeletal stability
and transcription [1]. Nuclear actin serves multiple func-
tions, both dependent and independent, on its role in
polymerization of actin filaments [2–5]. Spontaneous
actin assembly is inefficient and the cell uses a number
of actin nucleating promoting factors to obtain rapid
and dynamic actin polymerization [6]. The Wiskott–Al-
drich syndrome (WASp) family of nucleating promoting
factors all contain a verprolin-cofilin-acidic (VCA) do-
main that binds to the actin-related protein (Arp)2/3
complex to induce actin polymerization leading to for-
mation of branched filaments [6]. It has become increas-
ingly clear that actin nucleating promoting factors such
as the WASp family are present both in the cytoplasm
and in the nucleus. The WASp family of proteins in-
cludes WASp, neuronal (N)-WASp, and WASp-family
verprolin-homologous protein (WAVE)/suppressor of
the cyclic AMP receptor (SCAR) 1-3, WASp and SCAR
homologue (WASH), and junction-mediating and regu-
latory protein (JMY) [7]. The activity of WASp, N-
WASp, and WAVE/SCAR 1-3 are regulated by the Rho
family GTPases Cdc42, Rac1, and Rac2. At rest, WASp
and N-WASp resides in an auto-inhibited conformation
due to an intramolecular interaction between the VCA
domain and the GTPase-binding domain. Upon binding
of Cdc42, the auto-inhibited conformation is released
and exposes the VCA domain that allows for recruitment
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of the Arp2/3 complex and actin polymerization [8–10].
Rac1 and Rac2 regulate activation of the multimeric
WAVE/Scar regulatory complex to stimulate actin
polymerization by the VCA domain [11–13].
All steps of T cell development in thymus is coordi-
nated by the actin cytoskeleton to control cycles of T cell
migration and stable immunological synapse assembly
with antigen-presenting stroma cells and dendritic cells
[14]. Moreover, the development of T cells from multi-
potent progenitor cells depends on fine-tuned regulation
of transcription factors (TFs), resulting in the loss of al-
ternative lineage potential and the acquisition of the T
cell functional identity. This lineage commitment relies
on Notch signaling and the activity of TFs such as the
high mobility group (HMG) family of TFs T cell factor
(TCF)1, lymphoid enhancer factor (Lef )1, and the E-box
proteins TCF12/HeLa E-box-binding protein (HEB), E2-
2, and E2A [15, 16]. In thymus, T cells develop from
CD4–CD8– double-negative thymocytes to express a
functional T cell receptor (TCR) upon which they be-
come CD4+CD8+ double-positive thymocytes. The CD4
+CD8+ double-positive thymocytes constitute more than
80% of all cells in the thymus and develop into CD4
+CD8– and CD4–CD8+ single-positive T cells that leaves
the thymus and enter into the circulation as mature
CD4+ and CD8+ T cells.
WASp is uniquely expressed in hematopoietic cells
and its role for their normal function have been exten-
sively studied in Wiskott–Aldrich syndrome (WAS) pa-
tients that lack expression of WASp and in gene-
targeted mice (WASp KO mice) [17, 18]. These studies
have revealed WASp to be critical for correct T cell
function and 40–70% of WAS patients develop T cell-
mediated autoimmunity [17–22]. This could at least in
part be due to a limited and more autoreactive T cell re-
ceptor repertoire in peripheral blood T cells from WAS
patients [23–26] and in thymocytes and spleen T cells
from WASp KO mice [27]. WASp KO thymocytes and
T cells show decreased proliferation in response to T cell
receptor stimulation [21, 28, 29] and this is associated
with reduced translocation of nuclear factor of activated
T cells (Nfatc)2 into the nucleus of WASp KO T cells
upon T cell receptor stimulation, leading to decreased
expression of interleukin-2 [30–32]. X-linked neutro-
penia (XLN) is a more recently described WASp-
associated disease caused by point mutations
(WASpL270P, WASpS272P, WASpI276S, and WASpI294T) in
the WASp GTPase-binding domain that renders WASp
constitutively active by destroying the autoinhibited fold-
ing of WASp [33–37]. Murine spleen T cells expressing
WASpL272P and WASpI296T (corresponding to human
WASpL270P and WASpI294T) have an increased load of
polymerized actin associated with decreased cell spread-
ing [37].
Using a chromatin immunoprecipitation (ChIP) on
array approach including 50 genes known to regulate
T helper (Th)1 and Th2 commitment, Vyas et al.
showed that nuclear WASp in peripheral blood T
cells interacts specifically with Tbx12-induced genes
for Th1 commitment [38]. Moreover, using in vitro
derived Th1 cells, WASp interacts with a subset of
SWItch/Sucrose Non-Fermentable (SWI/SNF) com-
plexes to drive transcription of Tbx12-induced genes
[39]. Other interaction partners of WASp in the nu-
cleus remain to be identified. Although WASp has
been extensively investigated in proximity to T cell
receptor signaling in the cytoplasm, the role of nu-
clear WASp for T cell development remains to be
identified and should be important to fully under-
stand the pathophysiology of WASp-associated im-
munodeficiency diseases.
To identify the global gene occupancy by WASp in the
nucleus during T cell development, we took the un-
biased approach to perform ChIP sequencing (ChIP-seq)
and compare thymocytes (immature T cells) and spleen
CD4+ T cells (mature T cells). We identify 15 common
WASp-enriched genes, including the gene encoding for
TCF12. By comparing wild type (WT), WASp KO,
WASpL272P, and WASpI296T thymocytes from gene-
targeted mice, our data show that the activation status
of WASp affects TCF12 protein in the nucleus. We iden-
tify a putative WASp DNA-binding site identical to the
TCF1-binding site and we show that WASp interacted
with TCF1 in the nucleus. Together, we define that nu-
clear WASp acts in proximity with TCF1 and TCF12,
important for normal T cell development.
Methods
Mice
WASpL272P mice (C57Bl/6 ES cells, C57Bl/6 back-
ground) and WASpI296T mice (mixed 129Sv and C57Bl/
6 ES cells, backcrossed for eight generations to C57Bl/6
background) were generated by insertion of a point mu-
tation into germline WASp exon 9; TTG to CCG to gen-
erate the Leu-272 to Pro-272 knock-in mutation or ATT
to ACT to generate the Iso-296 to Thr-296. The
WASpL272P and WASpI296T knock in strains were gener-
ated by Ingenious Targeting Laboratory. WASp KO
(C57Bl/6 background) [40], WASpL272P, WASpI296T, and
littermate age- and sex-matched WT mice were bred
and maintained at the animal facility of the Department
of Microbiology, Tumor and Cell Biology at Karolinska
Institutet under specific pathogen-free conditions. Males
were used at six weeks of age and all animal experiments
were performed after approval from the local ethical
committee (the north Stockholm district court); protocol
approval number: N77/13.
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Mouse primary cells and cell cultures
WT, WASp KO, WASpL272P, and WASpI296T thymocytes
were isolated by thymi homogenization through 100-μm
strainers (Corning) and cell resuspension in sterile cold 1x
PBS. Ten thymi of a specific genotype were pooled and
used per ChIP experiment. WT, WASp KO, WASpL272P,
and WASpI296T CD4+ T cells were isolated by spleen
homogenization through 100 μm strainers (Corning)
followed by splenocytes-derived T cell isolation using CD4
+ T Cell Isolation Kit (Miltenyi). The purity of CD4+CD3+
T cells was 94–96% (Additional file 1: Figure S1). Cell lines
used: murine fibroblast L-cells (ATCC no. CRL-2648) and
A20 (mouse reticulum cell sarcoma lymphoblast lympho-
blastoma) cell line (ATCC no. TIB-208). Experiments that
were from different biological samples (cells or mice) and
performed at least twice and consistently measured are
considered biological replicates. Consistent measurements
of one biological sample performed at least twice are con-
sidered technical replicates.
Cell fractionation and immunoprecipitation (IP)
Mouse thymi were collected and cell suspension prepared
with the use of 100-μm strainers (Corning). For cell frac-
tionation, the Nuclear/Cytosol Fractionation Kit #K266-25
(BioVision) was used. For IP, a protease inhibitors cocktail
(SigmaAldrich) was added to all buffers and lysis solu-
tions. 108 cells/mL were washed twice with cold 1x PBS
containing a protease inhibitors cocktail (Sigma-Aldrich),
sedimented in Eppendorf centrifuge (2000 rpm, 5 min, 4 °
C). Total cell lysates were prepared by incubation on ice
for 30 min of the cell pellet in equal volume of lysis buffer
containing NP-40, followed by centrifugation (14,000 rpm,
15 min, 4 °C). Supernatants were collected and pre-
cleared by adding 100 μL of pre-equilibrated rec-Protein
G-Sepharose® 4B Conjugate (Invitrogen) suspension per
sample. Ten to 20 μL of antibodies were added to pre-
cleared supernatant and immunoprecipitation performed
during 10 h at 4 °C on shaking platform. Afterwards,
100 μL of pre-equilibrated protein G-Sepharose beads sus-
pension per sample was added to the IP samples with con-
tinued incubation during 4 h at 4 °C on shaking platform.
Triple wash of IP samples was performed via beads re-
suspension in 1 mL of cold 1x PBS followed by centrifuga-
tion (1000 rpm, 3 min, at 4 °C) and collection of super-
natant. One hundred microliter aliquots of loading and
three washes were collected and stored frozen at –20 °C.
Bead pellets were re-suspended in 300 μL of 4x Laemmli
gel loading buffer. Samples were heated at 95 °C in a solid
block thermostat for 10 min and centrifuged (1500 rpm,
5 min, room temperature). Collected supernatant aliquots
were stored at –20 °C and used for western blotting ana-
lysis as described. Ten to 20 μL of purified mouse IgG2A
(#401501, Biolegend) was used as the isotype antibody
(Ab)-negative control in co-IP experiment.
Chromatin immunoprecipitation (ChIP)
Three rounds of sample preparation for ChIP-seq were
made. (1) High stringency condition was used for ChIP
of WT thymocytes with the WASp Ab or an isotype
control. Only the WASp ChIP sample could be used for
sequencing since the isotype control sample had too low
DNA concentration by Bioanalyzer analysis for sequen-
cing (Additional file 1: Figure S2B). (2) To obtain
enough DNA for sequencing, the WT spleen CD4+ T
cell sample was prepared under low stringency for
WASp ChIP (Additional file 1: Figure S2C). An Ab-free
WT spleen-negative control sample was sequenced and
all hits present in this sample were subtracted from the
WASp ChIP-seq data of the WT spleen CD4+ T cells
(Fig. 1c). (3) ChIP samples from WT, WASpI296T, and
WASp KO thymocytes were prepared under low strin-
gency. The WASp KO thymocyte sample had too low
DNA concentration by Bioanalyzer for sequencing (Add-
itional file 1: Figure S2D). To detect differential DNA
interaction between WASpI296T and WT WASp, we re-
moved all similar hits between the two samples to iden-
tify the unique genome occupancy by WASpI296T. The
ChIP protocol was performed with high stringency or
low stringency in regard to fixation and washing condi-
tions. Two milliliters of single-cell suspension per ChIP
sample containing 1–2 × 108 cells were used. For high
stringency, cells were cross-linked with 1% FA for
15 min, and for low stringency, cells were cross-linked
with 10 mM DMA (linker arm length 8.6 Å, Pierce) for
1 h ± 0.75% FA for 5 min. Cross-linking was followed by
a 20-min incubation with 137 mM glycine to quench the
formaldehyde cross-linking. Cells were washed twice
with cold 1x PBS, harvested by centrifugation, resus-
pended in 1x PBS, and briefly sonicated on ice using
Bioruptor UCD-200 sonication system (Diagenode) at a
setting of 5 for 30-s pulses with a 30-s pause between
pulses. Cell lysates were treated with 100 U/mL benzo-
nase (Merck) for 40 min at room temperature with slow
rotation and the nuclease reaction was stopped by
addition of EDTA to a final concentration of 5 mM.
After quenching of the benzonase reaction, the samples
were centrifuged at 20,000 g for 15 min at 4 °C. The
supernatant was collected and 10% (volume) of the
supernatant was stored (–20 °C) for further ChIP-seq in-
put control DNA analysis. Ten microliters of monoclo-
nal anti-WASp F-8 Ab (Santa Cruz Biotechnology) were
added to the rest of pre-cleared supernatant and immu-
noprecipitation was performed during 10 h at 4 °C on
shaking platform. Resulted ChIP samples were added to
100 μL per sample of pre-equilibrated protein G-
Sepharose beads suspension with further incubation dur-
ing 4 h at 4 °C on shaking platform. Triple wash of IP
samples was performed via beads re-suspension in 1 mL
of cold 1x PBS followed by centrifugation (1000 rpm,
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3 min, 4 °C) and collection of supernatant. For high
stringency, the beads were washed twice with RIPA buf-
fer, pH 7.6 (50 mM HEPES-KOH pH 7.6, 100 mM NaCl,
1 mM EDTA, 500 mM LiCl, 1% NP-40, 0.7% sodium
deoxycholate). For low stringency, the beads were
washed twice with cold 1x PBS or TE buffer containing
50 mM NaCl. Finally, beads were re-suspended in elu-
tion buffer, pH 8.0 (1% SDS, 50 mM tris-HCl, 10 mM
EDTA) and incubated for 2 h at 65 °C followed by incu-
bation for 10 h at 56 °C with 100 μL/mL proteinase K,
#19133 (QIAGEN). Quality control of ChIP DNA frag-
ments was performed using Bioanalyzer 2100 with High
Sensitivity DNA Kit, #5067-4626 (Agilent) to ensure that
the size of DNA fragments was in the range of 100–
800 bp (Additional file 1: Figure S2A). Library construc-
tion for ChIP-seq and DNA sequencing (10 M clean
data) using the Illumina Genome Analyzer platform was
performed at Beijing Genome Institute (BGI, Shenzhen).
ChIP validation polymerase chain reaction (PCR) was
performed on a number of identified gene targets to
confirm specific DNA enrichment vs. ChIP Ab-free
negative control sample.
Western blotting
Western blotting was performed using the Bolt electro-
phoresis system (Invitrogen) and Bolt™ 4–12% Bis-Tris
Plus polyacrylamide gels NW04120BOX (Thermo Fisher
Scientific) in 1x Bolt® MOPS SDS Running buffer B0001
(Thermo Fisher Scientific). Blots were processed in 1x
TBS-T buffer containing 5% non-fat dry milk #1706404
(Bio-Rad) with antibodies used as follows: WASp F-8
(Santa Cruz Biotechnology), TCF1 H-118 (Santa Cruz
Biotechnology) diluted 1:200, TCF12 PA5-21039 (Invi-
trogen) diluted 1:300, GAPDH (FL-355, Santa Cruz Bio-
technology) diluted 1:1000, histone H3 (ab1791, Abcam)
diluted 1:10,000. Detection of GAPDH was used as a
sample loading control for total lysate and for cytosolic
extract. Detection of histone H3 was used as a sample
loading control for nuclear extract. Blots were developed
using IgG-HRP labeled antibodies (Santa Cruz Biotech-
nology) and the ECL detection system. Blot images were
analyzed using the ImageQuant LAS 4000 LAS4000
Image system using ImageQuant LAS 4000 Control
Software (GE Healthcare). The images of pre-stained
Protein Standard SeeBlue Plus2 LC5925 (Thermo Fisher
Scientific) and sample loading controls derived from the
same gel run, were overlaid onto blot image using
Adobe Photoshop CS6. The quantification of protein
band intensity on western blots was performed using
ImageJ software and normalized integrated signal density
was determined with Excel software.
Fluorine-conjugated UTP (FUrd) incorporation
transcription assay
For the in vivo run-on assays to monitor nascent precur-
sor RNA polymerase II transcripts [41], the thymocyte
cell suspension was incubated with 0.04 μg/mL of acti-
nomycin D in RPMI media for 2 h, then cells were
treated with 2 mM FUrd (Sigma-Aldrich) for 15 min. To
stop the reaction, cells were washed twice with cold 1x
PBS; then the cell suspension was applied on glass slides.
Cells were fixed using 3.7% formaldehyde in 1x PBS,
permeabilized with 0.5% Triton -X100 in 1x PBS, then
incubated with anti-BrdU Ab (Life Technology) to detect
FUrd incorporation into nascent RNA. In addition, anti-
histone H3 ab1791 (Abcam) was applied for the detec-
tion of nuclei pattern. For the microscopy analysis, cells
were mounted in Prolong Gold mounting medium con-
taining DAPI (Molecular Probes) and a single image
representing the focal plane was captured using Leica
DMRXA microscope at × 200 and × 1000 magnifications.
Several randomly distributed cells were captured for
each sample. Images were processed using Openlab 3.1.4
software (Improvision) and Adobe Photoshop 8.0. For
quantification, the cells as defined by DAPI signal were
outlined and the integrated density of FUrd fluorescence
signal was calculated using ImageJ software. Ten cells
with the brightest FUrd signal found on each image were
(See figure on previous page.)
Fig. 1 ChIP-seq analysis of WASp enriched genes. a The F-8 anti-WASp Ab specifically recognizes WASp in total thymocyte lysates, nuclear ex-
tracts (NE), and cytosolic extracts (CE). Heavy chain of mouse IgG (IgGhc) is observed in eluted IP samples. GAPDH was used as a sample loading
control for total lysates. b WASp is abundant in NE of WT thymocyte when compared to NE of WT spleen CD4+ T cells. Heavy chain of mouse
IgG (IgGhc) is observed in eluted IP samples. GAPDH was used as a sample loading control for total lysates. These data are representative of four
(thymus fractionation) and two (spleen CD4+ T cell fractionation) independent biological replicates. c ChIP-seq analysis of thymocytes and spleen
CD4+ T cells flowchart. WASp-enriched genes by ChIP-seq analysis of WT thymocytes performed under high stringency condition. WASp-enriched
genes by ChIP-seq analysis of spleen CD4+ T cells performed under low stringency conditions and compared to a ChIP-seq dataset from control
Ab-free spleen CD4+ T cells. All common genes were subtracted from the spleen CD4+ T cells dataset. Both ChIP-seq datasets were then aligned
and compared to identify common genes in thymocytes and spleen CD4+ T cells. d Distribution of distance from WASp ChIP-seq gene peaks to
the nearest transcription start site (TSS) defined according to the positions of RefSeq TSSs using the CHIPseek software. Negative values indicate
5’ of the TSS, positive values indicate 3’ of the TSS. e Annotation of WASp ChIP-seq gene peak positions within intergenic and genic regions using
CHIPseek software. By default promoter-TSS annotation defined as area from – 1 kb to + 100 bp of the TSS position and transcription termination
site area (TTS) defined from – 100 bp to + 1 kb of the TTS position. f Functional groups of peak-corresponding genes in WASp ChIP-seq refined
datasets. Additional file 1: Figure S1–S3 and Additional file 3: sheets 1 and 2
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taken for subsequent analysis. The obtained integrated
density of the signal was normalized for the main value
found in the WT cells. Statistical analysis was performed
in GraphPad Prism and Excel software. Chosen sample
size covered all available detected signals in the limited
dataset of WASp KO mice in the first experimental
round. A similar sample size was chosen in available
WASpI296T mice in the second experimental round. To
create a balanced design, the same sample size was
chosen in WT mice in both rounds of experiments. Stat-
istical analysis of nested ANOVA was applied in both
rounds of experiments. Analysis in the first experimental
round—FUrd signal measurements in WASp KO vs.
WT mice—was performed with the following parame-
ters: exact values of N: 90 for each mice (nine images
with ten measured values); 180 for each genotype; defin-
ition of the center in WT1-3: 9603; 8069; 7686; defin-
ition of the center in WASp KO1-3: 3613; 3832; 5150;
mean ± SD in WT1-3: 11,420 ± 7007; 9644 ± 5532;
10,019 ± 6145; mean ± SD in WASp KO1-3: 6374 ± 5540;
5448 ± 3959; 7046 ± 4882. Analysis in the second experi-
mental round—FUrd signal measurements in WASpI296T
vs. WT mice—was performed with following parameters:
exact values of N: 60 for each mice (six images with ten
measured values); 240 for each genotype; definition of
the center in WT1-4: 782,452; 507,618; 703,523;
577,830; definition of the center in WASpI296T1-4:
660,231; 503,051; 517,926; 587,749; mean ± SD in WT1-
4: 857,222 ± 434,228; 686,248 ± 518,108; 781,260 ±
452,743; 645,974 ± 299,508; mean ± SD in WASpI296T1-4:
753,605 ± 401,440; 564,983 ± 247,523; 701,733 ± 537,852;
612,138 ± 279,542. Exact p values in FUrd incorporation
transcription assay in the first experimental round
(WASp KO vs. WT): p = 0.0046; in the second experi-
mental round (WASpI296T vs. WT): p = 0.2337.
Real-time quantitative PCR-based gene expression
profiling
Gene specific primers designed with Primer Bank soft-
ware are listed in Additional file 2. Total RNA from thy-
mocytes was isolated with RNeasy kit #74104
(QIAGEN). Genomic DNA nuclease treatment with
RNAse-free DNAse kit # 79254 (QIAGEN) was per-
formed during isolation procedure for each prepared
total RNA sample. The concentration of isolated total
RNA was measured by NanoDrop 2000 (Thermo Scien-
tific). The visual quality control for RNA integrity and
purity was performed by 1% UltraPureAgarose,
#16500500 (Invitrogen), 1x TAE gel electrophoresis ana-
lysis. Gel images were created with ImageQuant LAS
4000 LAS4000 Image system using ImageQuant LAS
4000 Control Software (GE Healthcare). Two micro-
grams of total RNA per sample was used for each com-
plementary DNA (cDNA) synthesis reaction (with
SuperScript™ II Reverse Transcriptase, #18064-014 (Invi-
trogen). Real-time quantitative PCR (RT-qPCR) reac-
tions were performed using SsoAdvanced™ Universal
SYBR® Green Supermix kit, #1725272SP (Bio-Rad) with
C1000/CFX96 RT-PCR System (Bio-Rad). Gene expres-
sion profiling by RT-qPCR was performed in three tech-
nical replicates for each cDNA template sample with Ct
variation between triplicates less than cut-off ± 0.25.
Gene expression data: the mean of the technical tripli-
cate, ΔCt, RQ value, and standard deviation between RQ
of biological triplicates were calculated and analyzed
using Excel software.
Bioinformatics analysis
Standard bioinformatics analysis of ChIP-seq data was
performed by BGI (Shenzhen, Guangdong, China) includ-
ing primary data filtering to remove adaptor sequences,
contamination and low-quality reads from raw reads, read
alignment, and genome-wide distribution of ChIP-seq
reads (Table 1), general classification of all hits, GO func-
tion analysis of peak-related genes, sequence analysis
using Motif discovery tool (MEME) and Motif Alignment
and Search Tool (MAST). Peaks were identified using
peak calling approaches MACS (Model-based Analysis for
ChIP-Seq) and SICER (spatial clustering approach for the
identification of ChIP-enriched regions) [42–44]. Differen-
tial binding peaks were obtained by software MAnorm as
described [45]. Functional classification of refined data for
peak-related genes was performed using NCBI Gene re-
source (Bethesda, MD, USA). All hit classification dia-
grams were made with Excel software. Distribution of
distances from gene peak reads to the nearest transcrip-
tion start site (TSS) were defined according to the posi-
tions of RefSeq TSSs using ChIPseek software [46].
Genomic annotation of gene peak positions within inter-
genic and genic regions was received using ChIPseek soft-
ware. By default, promoter-TSS annotation is defined as
the area from – 1 kb to + 100 bp of the TSS position and
the transcription termination site area (TTS) is defined
from – 100 bp to + 1 kb of the TTS position [46]. DNA-
binding site inference for DNA-interacting protein partner
of WASp was assessed by applying TRANSFAC® software
[47]. Distribution of activating and repressive epigenetic
marks and specific TF sites in selected candidate genes re-
sulted from ChIP-seq data was examined using the UCSC
Genome Browser tool suite. Intra-intronic positions of
certain peak reads and distances from peak reads to near-
est exon of genes selected from ChIP-seq data were identi-
fied with UCSC Genome Browser tool suite.
Results
WASp localizes to the nucleus in thymocytes
To examine the presence of WASp in the nucleus dur-
ing development of T cells, nuclear and cytosolic
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extracts were prepared from thymus single-cell suspen-
sion consisting of > 98% thymocytes and from spleen
CD4+ T cells. We reasoned that WASp may not be an
easy protein to ChIP for based on its high homology to
N-WASp and the fact that WASp may be associated
with actin. To avoid cross-reactivity with N-WASp, we
tested a panel of anti-WASp antibodies and screened
them on cell lysates from WT and WASp KO thymo-
cytes. We identified that the WASp F-8 Ab specifically
detected WASp in total lysates from WT thymocytes
while no band was detected in WASp KO thymocytes
(Fig. 1a). To examine if WASp was present in the nu-
cleus of thymocytes, nuclear and cytosolic extracts were
prepared and WASp was detected both in nuclear and
cytosolic extracts and could be immunoprecipitated
from the nuclear and cytosolic extracts (Fig. 1a). When
comparing immunoprecipitated WASp from nuclear and
cytosolic extracts from thymus and spleen CD4+ T cells,
WASp was almost exclusively detected in the thymus
nuclear extract; much less WASp was detected in the
nuclear extract of spleen CD4+ T cells (Fig. 1b). These
data show that the WASp F-8 Ab immunoprecipitates
WASp from nuclear and cytosolic extracts of thymocytes
and to a lesser extent from spleen CD4+ T cells.
WASp interacts with DNA in both intergenic and genic
regions
To investigate the potential association of WASp with
the mammalian genome, we prepared thymocyte and
spleen CD4+ T cells lysates and performed ChIP-seq
analysis using the WASp F-8 Ab. Since thymocyte nu-
clear extracts contained abundant WASp, ChIP-seq was
performed under high stringency for cross-linking/wash-
ing (1% formaldehyde [FA]/RIPA wash, Additional file 1:
Figure S2A, B). The total number of reads were normal-
ized and aligned against the mouse genome to identify
regions enriched for WASp binding (Additional file 1:
Figure S2E). We identified 311 WASp enriched genes in
the WASp ChIP dataset from WT thymocytes (Fig. 1c).
For spleen CD4+ T cells with less WASp in the nucleus,
ChIP-seq was performed under low stringency for cross-
linking/washing (10 mM dimethyladipimidate [DMA] ±
0.75% FA/PBS wash, Additional file 1: Figure S2C). To
circumvent this difference in ChIP sample preparation
between thymus and spleen CD4+ T cells, we included
an Ab-free control for spleen CD4+ T cells performed
under low stringency (Additional file 1: Figure S1C). For
analysis of spleen CD4+ T cells, all genes present in the
Ab-free dataset were subtracted from the WASp ChIP
sample (Fig. 1c). Since 54 of the genes from the Ab-free
dataset were found in the thymocyte WASp ChIP-seq
dataset, we excluded these 54 genes from the thymocyte
dataset (Fig. 1c). Upon extraction of the sequences in
the Ab-free control, the ChIP-seq datasets from thymo-
cytes contained 257 WASp-interacting genes (Fig. 1c
and Additional file 3: sheet 1) and 455 WASp-
interacting genes from spleen CD4+ T cells (Fig. 1c and
Additional file 3: sheet 2). When the ChIP-seq datasets
from thymocytes and spleen CD4+ T cells were com-
pared, 15 common WASp-interacting genes were identi-
fied (Fig. 1c). To confirm efficiency of performed ChIP
procedure, selected genes were validated by RT-qPCR
using the ChIP samples from thymocytes (Additional file
1: Figure S2G, H). Moreover, we sequenced the thymo-
cyte and spleen CD4+ T cell input ChIP samples and
found more than tenfold enrichment of WASp ChIP-seq
enriched genes (Additional file 1: Figure S3). In thymo-
cytes and in spleen CD4+ T cells, WASp was clustered
around the TSSs (Fig. 1d) and WASp interacted with
both intergenic and genic regions of which the majority
were intron sequences (Fig. 1e). Functional clustering of
these genes using the NCBI Gene resource revealed that
WASp was associated with RNA Polymerase II genes in-
volved in a wide range of biological function that were
divided into 13 functional groups (Fig. 1f ). Among iden-
tified genes are TFs and co-factors (Nfatc2, TCF12,
Mllt1, Rprd1b, Rprd2, Taf1b, Zfp438), other DNA and
RNA-interacting proteins (Rad51d, Exosc10, Rbm20),
Table 1 ChIP sample statistics












WT thymus sample 1 Thymocytes Sample2 49 10955383 10625818 96.99 8955583 81.75




Sample4 49 31269031 30709811 98.21 27032898 86.45




Sample5 49 31288824 30704013 98.13 27032749 86.4
WT thymus sample 2 Thymocytes Sample12 49 9864439 9538121 96.69 8449710 85.66
WASp thymus I296T sample Thymocytes Sample13 49 15526660 15110656 97.32 13339372 85.91
WT thymus input control Thymocytes Sample2_input 49 12495831 12274173 98.23 10449083 83.62




Sample4_input 49 12658673 12522710 98.93 10976914 86.71
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regulators of signal transduction (Arhgap26, Phlpp1,
Vav2, Vav3), cytoskeleton-associated proteins (Alms1,
Cenpe, Nebl, Palld, WAVE2), and molecular motors
(Myh9, Myh10; see Additional file 3: sheets 1 and 2).
Genome-wide DNA occupancy of WASp associated with
RNA Polymerase II genes
We used the tools available at the University of Califor-
nia Santa Cruz (UCSC) genome browser to characterize
the association of the WASp ChIP-seq-binding profile
with RNA Polymerase II promoters and epigenetic
marks for active and repressed transcription as well as
association with peaks obtained by ChIP for specific TFs
and by DamID of genome-nuclear lamina interactions
for nuclear envelope lamin B1 [48] (Fig. 2a). Many of the
WASp-enriched genes were associated with RNA Poly-
merase II-enriched genes (Fig. 2a). WASp-enriched se-
quences of Tcf12 were associated with RNA Polymerase
II binding and active epigenetic marks of transcription;
H3K4m3, H3K9a, H3K27a, and with the epigenetic mark
for active enhancers H3K4m1 (Fig. 2a and b). WASp-
enriched sequences of Vav2 and WASf2 were associated
with RNA Polymerase II binding and active epigenetic
marks of transcription H3K27a and/or active enhancers
H3K4m1 (Fig. 2a and b). WASp-enriched sequences
were found close to the TSS of Nfatc2, Trim50, Nebl,
WASf2, Palld, Tcf12, Cct4, Sec24a, Rbm20, Zfp438, Zpbp
(Fig. 3a, Additional file 1: Figure S4A) and in deep in-
tronic regions for Vav2, Taf1b, and other genes (Fig. 3b,
Additional file 1: Figure S4B). These data suggest that
WASp associates at the promoter with RNA Polymerase
II and epigenetic marks for active transcription.
Global and gene-specific transcription is repressed in
WASp KO thymocytes
To examine the role of WASp in global gene transcrip-
tion, we performed a run-on transcription assay on liv-
ing cells in which fluorine-conjugated UTP (FUrd)
analogues are incorporated into nascent messenger RNA
(mRNA) molecules [41, 49]. Since WASp KO thymo-
cytes have reduced capacity to respond to T cell receptor
stimulation [21, 28–30], we examined mRNA transcrip-
tion in naïve thymocytes. When compared to WT thy-
mocytes, WASp KO thymocytes showed less intense
FUrd-rich foci, suggesting that WASp is required for
basal transcription (Fig. 4a, b). We next compared gen-
eral synthesis of nascent mRNA molecules in WT thy-
mocytes with thymocytes expressing the constitutively
active mutation of WASp, WASpI296T, and found similar
intensity of FUrd-rich foci in WT and WASpI296T thy-
mocytes (Fig. 4a, b).
To understand how WASp influences gene transcrip-
tion of specific genes, we next isolated total mRNA from
WT and WASp KO thymocytes and compared gene
expression using RT-qPCR. From the WASp ChIP-seq
dataset of WASp-interacting genes, we selected 76 genes
encoding for proteins associated with cytoskeletal net-
works and 76 genes encoding for proteins in transcrip-
tional networks and performed expression profiling
(Additional file 1: Figure S5). Many of these genes were
differentially expressed in WT and WASp KO thymo-
cytes (Fig. 4c), suggesting that WASp regulates gene
transcription at several loci.
We next compared expression of selected genes in-
cluding the 15 common WASp-interacting genes in the
ChIP-seq datasets for thymocytes and spleen CD4+ T
cells. Of these genes, 11 out of 17 genes showed lower
expression in WASp KO thymocytes when compared to
WT thymocytes, including Mir6369, Trim50, Vav2,
Phlpp1, Vav3, Prkca, Slc30a4, Plcb4, Prkcb, Zpbp, and
Tcf12 (Fig. 4d). Six out of 17 genes showed higher ex-
pression in WASp KO thymocytes when compared to
WT thymocytes, including Sec24a, Nebl, Nfatc2, Plcb1,
GM13152, and WASf2 (Fig. 4d). Together these data
suggest that WASp is involved in both transcription acti-
vation and repression of specific genes.
Gene regulation by nuclear WASpI296T
To examine the genomic distribution of the constitu-
tively active form of WASp [37], WASpI296T, we per-
formed ChIP-seq analysis using the WASp F-8 Ab under
low stringency conditions (10 mM DMA/PBS wash,
Additional file 1: Figure S2D). To pre-process raw ChIP-
seq data, the total number of reads were normalized and
aligned against the mouse genome to identify regions
enriched in WASpI296T binding (Additional file 1: Figure
S2F). We obtained differential binding peaks between
thymocytes expressing WT WASp or WASpI296T and
identified 70 WASpI296T-enriched genes (Fig. 5a and
Additional file 3: sheet 3). Functional clustering of these
genes revealed that WASpI296T was associated with RNA
Polymerase II genes in 11 functional groups (Fig. 5a).
Among the identified genes were regulators of signal
transduction (Lck, ZAP70), cytoskeleton-associated pro-
teins (Coro2a), and molecular motors (Myo1b, Supple-
mentary file 1 sheet 3). From the ChIP-seq dataset of
WASpI296T-interacting genes, we selected 16 genes and
performed expression profiling (Fig. 5b). Of these genes,
six of the 16 genes showed lower expression in WAS-
pI296T thymocytes when compared to WT thymocytes,
including Gas7, Thrb, Ap3m2, Tmem189, Ccdc88a, and
ZAP70 (Fig. 5b). Ten of the 16 genes showed higher ex-
pression in WASpI296T thymocytes when compared to
WT thymocytes, including Myo1b, Lck, Itgb3, Zcchc4,
Coro2a, Zc3h11a, SH3kbp1, Med12I, and Scaf8 (Fig. 5b).
Together these data suggest that thymocytes expressing
constitutively active WASpI296T had same intensity of
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Fig. 2 Transcription matrix for selected WASp enriched genes. a Bioinformatic association of WASp ChIP-seq peaks from our datasets with activating
(A) and/or repressive (R) epigenetic regulatory marks, RNA Polymerase II and TFs peaks and lamin B1 marks in thymocytes (T) and spleen CD4+ cells (S).
b Association of WASp ChIP-seq peaks in thymocytes of Tcf12, Vav2, and Wasf2 with RNA Polymerase II ChIP-Seq signal by TFBS ENCODE/LICR resource
at UCSC genome browser
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Fig. 3 Variation of distances from WASp ChIP-Seq gene peaks to nearest exon(s). Selected examples of genes with (a) shorter distance range
(0.5–5 kb) and (b) longer distance range (5–50 kb) between WASp ChIP-seq gene peak position and nearest exon. Additional file 1: Figure S4




Fig. 4 (See legend on next page.)
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basal gene transcription (Fig. 4a, b) and induced higher
expression of specific genes (Fig. 5b).
Association between WASp, TCF12, and TCF1 in the
nucleus
Tcf12 was one of the 15 WASp-enriched genes present
in both thymocytes and spleen CD4+ T cells. To under-
stand how the activity of WASp influences expression of
the Tcf12 gene, TCF12 was examined in T cells from
WT, WASp KO, WASpL272P, and WASpI296T mice, the
latter two expressing a constitutively active form of
WASp [37]. Since TCF12 is mainly localized in the nu-
cleus, we examined TCF12 in nuclear and cytosolic ex-
tracts from WT, WASp KO, WASpL272P, and WASpI296T
thymocytes. TCF12 was predominantly expressed in the
nuclear extract of WT thymocytes (Fig. 6a). WASp KO
thymocytes had significantly reduced TCF12 signal that
was barely detected in the cytosolic extracts (Fig. 6a).
This was in contrast to thymocytes expressing the con-
stitutively active form of WASp. Both WASpL272P and
WASpI296T thymocytes had increased TCF12 in the nu-
clear extract and in the cytosolic extract when compared
to WT thymocytes (Fig. 6a). These data suggest that the
activation status of WASp influences the level of nuclear
TCF12 protein in thymocytes.
To understand how WASp regulated Tcf12 expression,
we examined if WASp contained any described DNA-
binding structural motifs or documented DNA-
interacting properties and found no such evidence using
gene ontology tools provided by MGI at NCBI Gene re-
source (Additional file 4). This suggests that the associ-
ation of WASp with DNA may be indirect and mediated
by interaction with DNA-binding proteins. We analyzed
if there was any conserved DNA-binding site(s) in the
WASp-enriched sequences from the ChIP-seq datasets
from WT thymocytes and from WASpI296T thymocytes.
(See figure on previous page.)
Fig. 4 WASp functional status affects both basal and gene-specific transcription. a FUrd incorporation assays data for basal RNA polymerase II
nascent transcripts in WT, WASp KO, and WASpI296T thymocytes as determined by intensity of FUrd-rich foci (red). The cell nucleus is labeled with
DAPI (blue) and histone H3 (green). Note that mRNA transcripts can be seen in the cytoplasm already after 15 min. b Statistical analysis of FUrd
assay results by nested ANOVA. Each dot represents one image. Top: WT n = 3, WASp KO n = 3 in one experiment; bottom: WT n = 4, XLNI296T
n = 4 in one experiment. c, d Gene expression profiling by RT-qPCR of WASp ChIP-seq genes (c) encoding TFs, other DNA- or RNA-binding
proteins, and cytoskeletal network proteins performed on cDNA template of pooled samples: WASp KO n = 3 vs. WT n = 3 and (d) for common
WASp-enriched genes in thymocytes and spleen CD4+ T cells. Expression in WASp KO thymocytes is shown and compared with expression level
in WT thymocytes set to 1. Gene expression profiling by RT-qPCR was performed in three biological replicates: WASp KO n = 3 vs. WT n = 3 and in
three technical replicates for each cDNA template sample with Ct variation between triplicates less than cutoff ± 0.25. Gene expression data: the
mean of the technical triplicate, ΔCt, RQ value, and standard deviation between RQ of biological triplicates is indicated. See Additional file 1:
Figure S5
a b
Fig. 5 Gene regulation by nuclear WASpI296T. a Functional groups of peak-corresponding genes in WASp ChIP-seq refined datasets. b Gene
expression profiling by RT-qPCR of WASpI296T ChIP-seq genes in WASpI296T vs. WT thymocytes. Expression in WASpI296Tthymocytes is shown and
compared with expression in WT thymocytes set to 1. Gene expression profiling by RT-qPCR was performed in three biological replicates:
WASpI296T n = 3 vs. WT n = 3 and in three technical replicates for each cDNA template sample with Ct variation between triplicates less than
cut-off ± 0.25. Resulted gene expression data: the mean of the technical triplicate, ΔCt, RQ value, and standard deviation between RQ of biological
triplicates is indicated. Additional file 3: sheet 3





Fig. 6 (See legend on next page.)
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Interestingly, WASp-interacting sequences in WT thy-
mocytes were enriched for a DNA element identical to
the TCF1-binding site (Fig. 6b) [47]. WASpI296T-interact-
ing sequences from thymocytes were also enriched for at
DNA element with similarity to the TCF1-binding site
(Fig. 6b). We next examined if the Tcf12 gene contained
TCF1-binding sites. We identified several TCF1-binding
sites in Tcf12 introns 3 and 4 in close proximity to the
WASp-enriched sequences (Fig. 6c, Additional file 1:
Figure S6A). To examine TCF1 protein in nuclear and
cytosolic extracts from WT, WASp KO, WASpL272P, and
WASpI296T thymocytes, we used an Ab that is specific
for the longest TCF1 isoform that is transcriptionally ac-
tive due to its binding to β-catenin [50, 51]. TCF1 was
detected in all lysates with predominant localization in
the nuclear extracts (Fig. 6d). To determine if WASp
directly interacted with TCF1, WASp was immunopreci-
pitated from thymocyte nuclear extracts using the
WASp F-8 Ab and found to co-immunoprecipitate with
TCF1 (Fig. 6e). This suggests that WASp and TCF1 may
interact to drive transcription of TCF1 pathway genes
including Tcf1 itself. In support of this, the WASp ChIP-
seq dataset identified several WASp-interacting genes
that are induced by TCF1 signaling (Additional file 1:
Figure S6B). Together, these data suggest that nuclear
WASp acts in close proximity with TCF1 and TCF12
(see tentative model in Additional file 1: Figure S7).
Discussion
The contribution of nuclear WASp activity for T cell de-
velopment remains incompletely defined. Using
genome-wide analysis of the global genome occupancy
of WASp in T cells, we found that WASp interacted
with both intergenic and genic sequences and was
enriched at TSSs of a large number of protein-coding
genes. In the absence of WASp, RNA polymerase II
transcription was reduced, suggesting that WASp partic-
ipates in regulation of basal RNA polymerase II tran-
scription. We identified that WASp-enriched sequences
had a consensus-binding site identical to the TCF1-
binding site and that WASp interacted with TCF1 in the
nucleus. Moreover, we show that WASp interacted with
promoter-proximal introns of the gene encoding TCF12
and that the activation status of WASp influenced the
level of TCF12 protein in the nucleus.
WASp-enriched genes in thymus and spleen CD4+ T
cell samples shared similar features in regard to func-
tional groups and intragenic and genic occupancy. In
thymocytes, we found a large fraction of WASp in the
nuclear fraction when compared to the cytosolic frac-
tion. This was in contrast to spleen CD4+ T cells where
much less WASp was present in the nuclear fraction.
This suggests that the nuclear activity of WASp is im-
portant during thymocyte development. In spleen CD4+
T cells, the cytosolic activity of WASp in engaging prox-
imal T cell receptor signaling may become more import-
ant as shown in many studies [18]. We identified some
common genes when comparing global gene occupancy
by WASp in thymocytes and spleen CD4+ T cells (our
datasets) with the targeted ChIP on array approach for
genes that regulate Th1 and Th2 commitment [38, 39].
Among common WASp ChIP-seq enriched genes were
a mouse orthologue Mamld1 of previously reported
Mastermind like1 (MAML1) as well as other genes in-
volved in Notch signaling pathways including in thymo-
cytes Sbno2 and in spleen CD4+ T cells cadherin-6 and
Rbpj. We observed a number of regulatory genes associ-
ated with histone acetylation and deacetylation activities
including in thymocytes Kat6b (histone acetyltransferase
KAT6B) and in spleen CD4+ T cells Kansl1 (KAT8 regu-
latory NSL complex subunit 1), Sirt6 (NAD-dependent
protein deacetylase sirtuin-6), and Hdac8 (histone deace-
tylase 8). Previously identified genes such as Foxp3 and
Tbx1 [38, 39] were not found in our datasets.
The signature of the WASp-enriched genes suggested
that WASp serves a role both in basal RNA polymerase
II transcription and in regulation of specific genes. Al-
though basal RNA Polymerase II gene transcription was
lower in WASp KO thymocytes, we identified a few ex-
ceptions where expression of specific genes was upregu-
lated in WASp KO thymocytes. When comparing
WASp-enriched genes in thymocytes and spleen CD4+
T cells we found 15 common genes. Several of these
genes showed lower expression in WASp KO
(See figure on previous page.)
Fig. 6 The activation status of nuclear WASp affects TCF1-mediated Tcf12 expression. a TCF12 in NE and CE from WT, WASp KO, WASpI296T, and
WASpL272P thymocytes. These data were repeated twice with independent biological replicates. Detection of GAPDH was used as a sample
loading control for total lysate and for cytosolic extract. Detection of histone H3 was used as a sample loading control for total lysate and for
nuclear extract. The quantification of nuclear and cytosolic TCF12 in the western blot is shown in the right panel. b Consensus DNA motif
determined by WASp ChIP-seq data analysis and the canonical TCF1 DNA-binding site. c Proximity of WASp ChIP-seq gene peak positions and
TCF1-binding sites in Tcf12 intron 3. d TCF1 in NE and CE from WT, WASp KO, WASpI296T, and WASpL272P thymocytes. These data were repeated
twice with independent biological replicates. Detection of GAPDH was used as a sample loading control for total lysate and for cytosolic extract.
Detection of histone H3 was used as a sample loading control for total lysate and for nuclear extract. The quantification of nuclear and cytosolic
TCF1 in the western blot is shown in the right panel. e Co-IP of WASp and TCF1 from thymocyte nuclear extracts. These data were repeated three
times with independent biological replicates. Purified mouse IgG2A was used as the isotype Ab-negative control IP. Heavy chain of IgG (IgGhc) is
observed in eluted IP samples. Additional file 1: Figure S6 and S7 and Additional file 4
Kuznetsov et al. Genome Medicine  (2017) 9:91 Page 14 of 18
thymocytes including Vav2 and Vav3 that coordinate
proximal T cell receptor signaling to activation of the
Rho GTPases Rac1, Rac2, and Cdc42 and WASp family
members. Five of the 15 common WASp-enriched genes
were upregulated in WASp KO thymocytes. Of these,
WASp interaction with Nfatc2 is interesting since it sug-
gests that nuclear WASp may regulate Nfatc2 expression
and thereby production of interleukin-2. WASp KO T
cells have reduced translocation of Nfatc2 into the nu-
cleus upon T cell receptor stimulation [30] and we show
here that this may be compensated by increased expres-
sion of Nfatc2 in WASp KO thymocytes. WASf2, that
encodes for WASp family member WAVE2 also showed
increased expression in WASp KO thymocytes, suggest-
ing that loss of WASp stimulated transcription of
WAVE2. The WASp family members are known to be
able to compensate for each other to support actin
polymerization. N-WASp can compensate for loss of
WASp in development and function of B and T cells
[21, 52–54]. However, the compensation is not complete
as evident in increased frequency of autoreactive B and
T cells that only express N-WASp [20, 53–55]. Our data
provide an example where this cross-compensation be-
tween WASp family members may occur in the nucleus
through interaction of WASp with WASf2 and increased
gene expression of WASf2 in WASp KO cells.
Several WASp family members are present in the nu-
cleus and it is feasible to assume, based on their activity
in the cytoplasm, that they at least in part may exert
function in the open conformation exposing their VCA
domain. We provide evidence for that the active open
conformation of WASp in WASpL272P and WASpI296T
thymocytes showed same intensity of basal gene tran-
scription when compared to WT thymocytes, and had
higher expression of specific genes. Moreover,
WASpL272P and WASpI296T thymocytes had more nu-
clear TCF12 protein when compared to WT thymocytes,
perhaps indicating that a fraction of WT WASp resides
in an autoinhibited conformation that prevents over-
activation of WASp. Previous data suggest that gene
transcription regulated by a WASp family member can
be both dependent and independent on the VCA do-
main. In human T cells differentiated into Th1 cells, the
WASp-VCA domain is dispensable for gene transcrip-
tion of Tbx12-target genes [56]. Instead, sumoylation of
WASp at lysine residues is important for transcription
of this set of genes [57]. In Xenopus oocytes, WAVE1-
induced gene transcription and reprogramming is inde-
pendent of the WAVE1 VCA-like domain [58]. There
are also examples of WASp family members that require
the VCA domain and actin for gene transcription. In
HeLa cell nuclei, N-WASP is part of a large nuclear–
protein complex containing polypyrimidine-tract-
binding-protein-associated splicing factor–non-Pou-
domain octamer-binding protein/p54nrb (PSF–NonO),
nuclear actin, and RNA polymerase II [59]. The PSF–
NonO complex is involved in the regulation of many
cellular processes, such as transcription, RNA process-
ing, DNA unwinding, and repair. Interestingly, an N-
WASPΔVCA mutant localizes within the nucleus but is
defective in actin polymerization resulting in signifi-
cantly decreased gene transcription [59]. WASH is lo-
cated in the nucleus of hematopoietic stem cells where it
associates with the nucleosome remodeling factor
(NURF) complex and assists the NURF complex to the
promoter of the c-Myc gene necessary for hematopoietic
stem cell differentiation [60]. The nuclear activity of
WASH is dependent on nuclear actin polymerization in-
duced by the WASH VCA domain [60]. Together, these
studies raise the possibility that the multiple domains of
WASp family members may have unique biological
functions in the nucleus and that nuclear activity is reg-
ulated by the VCA domain as well as other functional
domains similar to the role of WASp family members in
the cytoplasm. In vitro, dimers or oligomers of WASp
family VCA domains bind with 100-fold higher affinity
to Arp2/3 when compared to monomers of VCA do-
mains [61]. This suggests that homo- and hetero-
dimerization of active WASp provides an additional
layer of regulation beyond conformation and functional
domains. Our data lend evidence to the open conform-
ation of WASp being required for global gene occupancy
and that constitutively active WASp in WASpL272P and
WASpI296T thymocytes induced increased transcription
of specific genes including Tcf12.
Here we identify that WASp targeted genes were
enriched for a DNA-binding site identical to the TCF1-
binding site. TCF1 is one of the earliest transcriptional
regulators induced in thymus and essential for T cell
commitment [62–64]. TCF1 is most abundant in CD4
+CD8+ double-positive thymocytes and its absence com-
promises CD4+CD8+ thymocyte survival [65, 66]. TCF1
constitutively interacts with DNA and mediates repres-
sion of gene transcription when bound to Groucho and
activation of transcription when bound to β-catenin
[67–69]. Bioinformatic analysis suggests that WASp
lacked DNA-binding properties. Instead, WASp inter-
acted with TCF1 leading to transcription of a subset of
target genes downstream of TCF1. This indicates that
WASp in complex with TCF1 may regulate transcription
of a subset of some but not all TCF1 pathway genes.
This suggests that the WASp-TCF1 interaction may be
complex and modulated by other binding partners and/
or modulators of transcription. Deletion of TCF1 specif-
ically in CD4+CD8+ double-positive thymocytes leads to
a skewed CD4/CD8 ratio with increased number of CD8
+ T cells [70]. Despite the reduction in basal RNA Poly-
merase II transcription and TCF1 pathway genes such as
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Tcf12, WASp KO thymocytes develop normally in regard
to number of CD4+ and CD8+ single-positive thymo-
cytes [21]. However, WASp KO mice have decreased
CD4/CD8 T cell ratio in peripheral organs, leading to in-
creased accumulation of CD8+ T cells in skin, spleen,
and lymph nodes [71]. Moreover, WASp-deficient thy-
mocytes and T cells have reduced capacity to respond to
T cell receptor stimulation [21, 28–30]. Therefore, it is
not surprising that an increasing number of reports have
identified aberrations in T cell development and differ-
entiation in WASp deficiency including an oligoclonal T
cell receptor repertoire often found in autoreactive T
cells [23–27], increased number of CD44+CD62L– ef-
fector memory T cells [21, 71], and T cell-driven auto-
immune colitis [20–22, 72]. Early studies of postmortem
examination of WAS patients showed thymic hypoplasia
[73], suggesting reduced thymic function and T cell de-
velopment. A reduction in peripheral blood T cell num-
ber is apparent already at an early age in WAS patient
and older patients have marked T cell lymphopenia [74–
76]. Together, this suggests that WASp deficiency leads
to aberrant T cell development and that thymocytes have
reduced capacity to undergo central tolerance check-
point to delete autoreactive T cells. The data presented
here support this idea by showing that the nuclear activ-
ity of WASp is important to regulate gene transcription
in a transcriptional network with TCF1 and TCF12 dur-
ing T cell development. Constitutive activation of the β-
catenin–TCF1 pathway is associated with genomic in-
stability and T cell lymphomas [77, 78]. Future studies of
nuclear WASp may reveal whether dysregulation of β-
catenin–TCF1 signaling is associated with increased fre-
quency of lymphoma in WAS patients.
Conclusions
To identify the global genome occupancy of WASp, we
have used ChIP-seq for WASp in thymocytes and spleen
CD4+ T cells. We found that WASp interacted with cod-
ing and non-coding DNA regions and that WASp defi-
ciency resulted in decreased RNA polymerase II
transcription. Finally, we identified a molecular network
important for T cell development placing nuclear WASp
in close proximity with TCF1 and TCF12.
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